Cargando…
AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy
ADP-ribosylation factor 1 (Arf1) plays a major role in mediating vesicular transport. Brefeldin A (BFA), a known inhibitor of the Arf1-guanine nucleotide exchange factor (GEF) interaction, is highly cytotoxic. Therefore, interaction of Arf1 with ArfGEF is an attractive target for cancer treatment. H...
Autores principales: | Ohashi, Yoshimi, Iijima, Hiroshi, Yamaotsu, Noriyuki, Yamazaki, Kanami, Sato, Shigeo, Okamura, Mutsumi, Sugimoto, Kenji, Dan, Shingo, Hirono, Shuichi, Yamori, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281721/ https://www.ncbi.nlm.nih.gov/pubmed/22158626 http://dx.doi.org/10.1074/jbc.M111.316125 |
Ejemplares similares
-
Role of NAD(+) and ADP-Ribosylation in the Maintenance of the Golgi Structure
por: Mironov, Alexander, et al.
Publicado: (1997) -
Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors
por: Ohashi, Yoshimi, et al.
Publicado: (2017) -
ADP-ribosylation of arginine
por: Laing, Sabrina, et al.
Publicado: (2010) -
Reversing ADP-ribosylation
por: Moeller, Giuliana Katharina, et al.
Publicado: (2017) -
ADP-Ribosylation Factor 1 (ARF1) Regulates Recruitment of the AP-3 Adaptor Complex to Membranes
por: Ooi, Chean Eng, et al.
Publicado: (1998)